Europe
Intranasal betahistine program progressing towards proof-of-concept studies in acute vertigo (AM-125) and antipsychotic-induced weight gain (AM-201)
DUBLIN - March 14, 2019 - Medtronic plc announced that its Board of Directors has appointed Andrea J. Goldsmith, Ph.D. to the Board as an independent director, effective March 11, 2019.
Molecular Health, a leading company in the field of data science for precision medicine and specializing in the development of products and services leveraging its proprietary biomedicine technology platform Dataome, has been shortlisted for the German Digital Health Award 2019.
Biotech and pharma companies make changes to their executive leadership teams, with moves at Sandoz, PAREXEL, FSD, Karuna, Precision Bio, and more.
On day two of Cowen and Company’s 39th Annual Health Care Conference, more companies shared insight into pipeline development. BioSpace rounded up a few of the stories.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
Francis’ last day with Sandoz will be March 31. Francesco Balestrieri, who is currently Region Head Europe for Sandoz, has been appointed interim CEO. He will report to Vas Narasimhan, the CEO of Novartis
MC Services AG, the international public relations and investor relations firm, announced that it will support, as a media partner, BIO-Europe Spring® 2019, Europe’s largest springtime partnering conference for the global life sciences industry.
The Minafin Group announces the launch of Minagro, a new global business unit dedicated to developing and marketing greener and safer ingredients for the crop care industry.
Interim data from all patients enrolled in ongoing L-MIND trial of MOR208 in combination with lenalidomide in relapsed/refractory DLBCL confirm activity suggested by earlier data cuts
PRESS RELEASES